Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 2000;7(2):57–62. doi: 10.1155/MBD.2000.57

Carbonic Anhydrase Inhibitors. Part 91. Metal Complexes of Heterocyclic Sulfonamides as Potential Pharmacological Agents in the Treatment of Gastric Acid Secretion Imbalances

Marc A Ilies 1, Claudiu T Supuran 2,, Andrea Scozzafava 2
PMCID: PMC2365199  PMID: 18475926

Abstract

Zinc, magnesium, aluminum and copper complexes of several potent, clinically used carbonic anhydrase (CA) sulfonamide inhibitors, such as acetazolamide, methazolamide, ethoxzolamide and benzolamide were tested for their possible applications as antacids, in experimental animals. Gastric acid secretion parameters 3 days after treatment with these CA inhibitors (2 × 500 mg, twice a day), in dogs with chronic gastric fistulas, led to the observation that the gastric acid parameters BAO (the basal acid output), and MAO (the maximal acid output after stimulation with histamine) were drastically reduced, as compared to the same parameters in animals that did not receive these enzyme inhibitors. These are promising results for the possible use of metal complexes of heterocyclic sulfonamides as treatment alternatives (alone or in combination with other drugs) for gastric acid secretion imbalances.

Full Text

The Full Text of this article is available as a PDF (947.7 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES